Selegiline , ≥98% , 14611-51-9

Synonym(s):
(-)-Deprenyl

CAS NO.：14611-51-9

Empirical Formula: C13H17N

Molecular Weight: 187.28

MDL number: MFCD00672171

EINECS: 604-507-3

PRODUCT Properties

• Melting point: 137.5-139 °C
• Boiling point: 273℃
• alpha: D20 -11.2°
• Density: 0.954
• refractive index: nD20 1.5180
• Flash point: 108℃
• storage temp.: -20°C
• pka: 7.53±0.50(Predicted)
• InChI: InChI=1/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3/t12-/s3
• InChIKey: MEZLKOACVSPNER-PLAQIDKDNA-N
• SMILES: C1(C=CC=CC=1)C[C@@H](C)N(C)CC#C |&1:7,r|

Description and Uses

Selegiline, a monoamine oxidase (MAO) inhibitor, is FDA-approved as an adjunct treatment in the management of patients with Parkinson disease and as a treatment for a major depressive disorder (MDD) in adults. Selegiline is also used off-label for early Parkinson disease and the treatment of attention-deficit/hyperactivity disorder (ADHD). 

Antidyskinetic; antiparkinsonian (in combination with levodopa/carbidopa).

Safety

• Symbol(GHS): GHS02,GHS06,GHS08
• Signal word: Danger
• Hazard statements: H225-H301+H311+H331-H370
• Precautionary statements: P210-P260-P280-P301+P310-P311
• Hazard Codes: F,T
• Risk Statements: 11-23/24/25-39/23/24/25
• Safety Statements: 7-16-36/37-45
• RIDADR: 1851
• WGK Germany: 1
• HazardClass: 6.1(b)
• PackingGroup: III